Talk:ICT

If you search for ICT in Wikipedia you are redirected to the (generally well-written and complete) article on Information Technology. However in search of accuracy IT and ICT are not equivalent.

In order to correct this, I have created a new article at http://en.wikipedia.org/wiki/Information_communications_technologies which addresses ICT in its own right.

I am requesting that the redirection for ICT to IT be removed in order that ICT can be viewed in its own right.

I am happy to discuss this further.

Cordially, Atenyi 14:05, 31 March 2007 (UTC)

Headline text

Research

Institute of Cancer Therapeutics Research Programmes Research at the Institute of Cancer Therapeutics encompasses the development of new cancer medicines from concept to clinic. The emphasis of the programme is on drug target interrogation in clinical samples and development of relevant in vitro and in vivo models for lead compound selection and progression. Research covers the three broad stages of cancer medicines development: discovery, pre-clinical evaluation and clinical application.

Medicinal chemistry and cancer drugs

Discovery programmes include the evaluation of novel targets for anticancer strategies allied to the synthesis of novel molecules aimed at these cancer specific targets. On-going programmes include the development of new anticancer agents that reduce the toxicity associated with existing chemotherapies and those targeted at circumventing tumour-resistance mechanisms. Medicinal chemistry research is the responsibility of the Synthetic and Medicinal Chemistry section of the Institute. This section researches the design and synthesis of chemical compounds which are evaluated for biological activity and their pharmacokinetics profile. Follow the link for more information on medicinal chemistry research and the development of drugs for cancer.

Pre-clinical evaluation

Pre-clinical evaluation of new molecular entities has formed the core of cancer research at Bradford University for many years. The pre-clinical and cancer pharmacology programmes play a key role in the progression of new drugs for cancer to the clinic. Activities in these areas include target characterisation and in vitro screening, in vivo screening and model development and DMPK and pharmacology. Follow the link for more information on pre-clinical evaluation of drugs for cancer. A YCR/University co-sponsored Proteomics and Mass Spectrometry laboratory is developing as a resource to interrogate specific target/drug interactions and global effects of agents on the experimental tumour proteome.

Clinical application

Research within the Institute is focussed on the development of clinically relevant cancer medicines for patients. The Institute of Cancer Therapeutics has an experienced Drug Metabolism and Pharmacokinetic (DMPK) Team which plays a central role in the drug delivery process within the Institute of Cancer Therapeutics. For more information, follow the link to the Drug Metabolism and Pharmacokinetic (DMPK) page.

We work closely with the Cancer Unit in the Bradford NHS Trust and Cancer Centre in Leeds. Our close links to the early clinic in Leeds are especially important as a potential route for new agents developed at the Institute to be taken into the clinic. Cancer medicines from concept to clinic home. —Preceding unsigned comment added by Dr khalil1 (talk • contribs) 21:48, 5 May 2009 (UTC)

how is the monitor like —Preceding unsigned comment added by 41.218.192.241 (talk) 16:43, 4 November 2009 (UTC)